Please check your internet connection and try again.
# Hepamerz (L-Ornithine L-Aspartate)
## Overview
Hepamerz is a combination of two amino acids, L-ornithine and L-aspartate, which are involved in the urea cycle and ammonia detoxification in the liver.
## Primary Indications
* Treatment of hyperammonemia associated with liver disease (e.g., cirrhosis).
## Adult Dosing
* **Intravenous (IV) infusion:** 5 grams to 30 grams per day, divided into 1 to 3 infusions. The exact dose and infusion rate should be determined by the treating physician and may depend on the severity of hyperammonemia and patient tolerance. Typical infusion rates are 5 grams per hour.
* **Oral (solution/granules):** 3 grams to 6 grams three times daily.
## Pediatric Dosing
* Dosing in pediatric patients is not well-established and should be managed by a physician experienced in pediatric liver disease.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, as the drug's metabolism is primarily hepatic, and it aids in liver function. However, caution and close monitoring are advised in patients with severe liver dysfunction.
## Contraindications
* Known hypersensitivity to L-ornithine, L-aspartate, or any component of the formulation.
* Severe renal insufficiency (creatinine clearance < 25 mL/min) due to potential accumulation of amino acids.
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal pain, diarrhea, flatulence.
* **Less Common:** Headache, dizziness, fatigue, skin rash.
* **Rare:** Allergic reactions.
## Key Drug Interactions
* Limited significant drug interactions are reported. However, caution may be warranted with other medications affecting ammonia levels or liver function.
## Monitoring
* Serum ammonia levels.
* Liver function tests.
* Renal function (especially if contraindications are being considered).
* Electrolytes.
* Patient's clinical status and symptoms of hyperammonemia.
## Clinical Pearls
* Hepamerz works by promoting ammonia detoxification through the urea cycle (ornithine) and by providing nitrogen for glutamine synthesis in the liver and peripheral tissues (aspartate).
* IV administration is typically used for acute, severe hyperammonemia, while oral formulations are used for chronic management.
* The drug's efficacy is directly related to the degree of ammonia reduction.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and your institution's protocols for the most current and complete guidance. Dosing and management should be individualized based on patient-specific factors.
